| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | phosphatase complex | 9.26e-05 | 55 | 90 | 4 | GO:1903293 | |
| GeneOntologyCellularComponent | protein serine/threonine phosphatase complex | 9.26e-05 | 55 | 90 | 4 | GO:0008287 | |
| GeneOntologyCellularComponent | protein phosphatase 4 complex | 2.72e-04 | 6 | 90 | 2 | GO:0030289 | |
| Domain | Spectrin/alpha-actinin | 1.50e-05 | 32 | 88 | 4 | IPR018159 | |
| Domain | SPEC | 1.50e-05 | 32 | 88 | 4 | SM00150 | |
| Domain | SMK-1 | 2.19e-05 | 2 | 88 | 2 | PF04802 | |
| Domain | DUF625 | 2.19e-05 | 2 | 88 | 2 | IPR006887 | |
| Domain | Spectrin_repeat | 3.38e-04 | 29 | 88 | 3 | IPR002017 | |
| Domain | WH1 | 1.66e-03 | 13 | 88 | 2 | PS50229 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.93e-03 | 14 | 88 | 2 | IPR024317 | |
| Domain | FN_type2_col-bd | 1.93e-03 | 14 | 88 | 2 | IPR000562 | |
| Domain | FN2_2 | 1.93e-03 | 14 | 88 | 2 | PS51092 | |
| Domain | Dynein_HC_stalk | 1.93e-03 | 14 | 88 | 2 | IPR024743 | |
| Domain | Myotubularin-like_Pase_dom | 1.93e-03 | 14 | 88 | 2 | IPR010569 | |
| Domain | MT | 1.93e-03 | 14 | 88 | 2 | PF12777 | |
| Domain | AAA_8 | 1.93e-03 | 14 | 88 | 2 | PF12780 | |
| Domain | PPASE_MYOTUBULARIN | 1.93e-03 | 14 | 88 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 1.93e-03 | 14 | 88 | 2 | IPR030564 | |
| Domain | Myotub-related | 1.93e-03 | 14 | 88 | 2 | PF06602 | |
| Domain | fn2 | 1.93e-03 | 14 | 88 | 2 | PF00040 | |
| Domain | FN2_1 | 1.93e-03 | 14 | 88 | 2 | PS00023 | |
| Domain | FN2 | 1.93e-03 | 14 | 88 | 2 | SM00059 | |
| Domain | BTB_2 | 2.00e-03 | 53 | 88 | 3 | PF02214 | |
| Domain | T1-type_BTB | 2.00e-03 | 53 | 88 | 3 | IPR003131 | |
| Domain | DHC_fam | 2.21e-03 | 15 | 88 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.21e-03 | 15 | 88 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.21e-03 | 15 | 88 | 2 | PF03028 | |
| Domain | GRAM | 2.52e-03 | 16 | 88 | 2 | SM00568 | |
| Domain | PH_dom-like | 3.97e-03 | 426 | 88 | 7 | IPR011993 | |
| Domain | - | 4.77e-03 | 22 | 88 | 2 | 1.10.196.10 | |
| Domain | DAPIN | 4.77e-03 | 22 | 88 | 2 | PS50824 | |
| Domain | GRAM | 4.77e-03 | 22 | 88 | 2 | PF02893 | |
| Domain | PYRIN | 4.77e-03 | 22 | 88 | 2 | PF02758 | |
| Domain | MAGE_N | 4.77e-03 | 22 | 88 | 2 | PF12440 | |
| Domain | GRAM | 4.77e-03 | 22 | 88 | 2 | IPR004182 | |
| Domain | DAPIN | 4.77e-03 | 22 | 88 | 2 | IPR004020 | |
| Domain | RGS_subdom1 | 4.77e-03 | 22 | 88 | 2 | IPR024066 | |
| Domain | PYRIN | 4.77e-03 | 22 | 88 | 2 | SM01289 | |
| Domain | MAGE_N | 4.77e-03 | 22 | 88 | 2 | IPR021072 | |
| Domain | Spectrin | 5.21e-03 | 23 | 88 | 2 | PF00435 | |
| Pubmed | AURKC CERK PPP2R2A MLH3 OBSL1 PEX1 RNF213 XPC NUP188 WDFY3 KAT6B CDKAL1 ADH4 NIN | 1.06e-06 | 1116 | 90 | 14 | 31753913 | |
| Pubmed | 2.05e-06 | 225 | 90 | 7 | 12168954 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 3.75e-06 | 351 | 90 | 8 | 20453000 | |
| Pubmed | PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis. | 6.62e-06 | 2 | 90 | 2 | 22826605 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16107728 | ||
| Pubmed | 9.65e-06 | 529 | 90 | 9 | 14621295 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 30077875 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 18683034 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PHKA2 AURKC PPP2R2A CDK12 AHCY OBSL1 PEX1 NUP188 DCK MAP2K2 AXIN2 | 2.35e-05 | 910 | 90 | 11 | 36736316 |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 3.17e-05 | 139 | 90 | 5 | 25476789 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 21423269 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 17688412 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 20876121 | ||
| Pubmed | Next-generation sequencing to generate interactome datasets. | BTN2A2 GJB2 PNLIPRP1 PYROXD1 AHCY SEPTIN1 WDFY3 FERMT2 PIAS2 PRRC1 CTSW SNX1 | 4.01e-05 | 1147 | 90 | 12 | 21516116 |
| Pubmed | SUMO-1 modification of centrosomal protein hNinein promotes hNinein nuclear localization. | 6.59e-05 | 5 | 90 | 2 | 16154161 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 20132320 | ||
| Pubmed | Genetic evidence for a mammalian retromer complex containing sorting nexins 1 and 2. | 6.59e-05 | 5 | 90 | 2 | 16214895 | |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 7.23e-05 | 85 | 90 | 4 | 16051665 | |
| Pubmed | PPP4R3B ARHGAP32 PPP2R2A IGF2R PTPRB DSP SBF2 RNF213 MTMR10 PPP4R3A NIN | 8.44e-05 | 1049 | 90 | 11 | 27880917 | |
| Pubmed | 8.73e-05 | 172 | 90 | 5 | 27375898 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 17101778 | ||
| Pubmed | PPP4R3B SESTD1 DSP SYNE1 AHCY OBSL1 XPC WDFY3 PIAS2 MTMR10 SNX1 TRIM52 | 1.18e-04 | 1285 | 90 | 12 | 35914814 | |
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 11934864 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.46e-04 | 588 | 90 | 8 | 38580884 | |
| Pubmed | Centrosome-related genes, genetic variation, and risk of breast cancer. | 1.47e-04 | 102 | 90 | 4 | 20508983 | |
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 1.64e-04 | 105 | 90 | 4 | 19156129 | |
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 14752048 | ||
| Pubmed | Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. | 1.84e-04 | 8 | 90 | 2 | 15215868 | |
| Pubmed | A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. | 1.84e-04 | 8 | 90 | 2 | 18614045 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PHKA2 PPP2R2A SYNE1 KCTD10 CALCOCO1 AHCY XPC NUP188 RBM39 PRRC1 VPS13B | 1.96e-04 | 1155 | 90 | 11 | 20360068 |
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 28467410 | ||
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 16239230 | ||
| Pubmed | 2.41e-04 | 335 | 90 | 6 | 15741177 | ||
| Pubmed | 2.57e-04 | 339 | 90 | 6 | 37232246 | ||
| Pubmed | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | 2.69e-04 | 342 | 90 | 6 | 23128233 | |
| Pubmed | 2.74e-04 | 486 | 90 | 7 | 20936779 | ||
| Pubmed | A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. | 2.83e-04 | 121 | 90 | 4 | 19789190 | |
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 20503258 | ||
| Pubmed | Evolution of the regulators of G-protein signaling multigene family in mouse and human. | 3.19e-04 | 51 | 90 | 3 | 11829488 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 3.52e-04 | 670 | 90 | 8 | 22990118 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 3.70e-04 | 363 | 90 | 6 | 14691545 | |
| Pubmed | 4.30e-04 | 12 | 90 | 2 | 29180410 | ||
| Pubmed | ZC3H7A IGF2R MTX2 MRS2 SYNE1 OBSL1 FERMT2 DNAJC3 VPS13B SNX1 CDKAL1 NIN | 4.48e-04 | 1487 | 90 | 12 | 33957083 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 4.49e-04 | 695 | 90 | 8 | 23602568 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PPP2R2A PTPRB SBF2 CALCOCO1 RNF213 KAT6B MAP2K2 DNAJC3 RBM39 VPS13B DNAH14 SBNO2 | 4.53e-04 | 1489 | 90 | 12 | 28611215 |
| Pubmed | Apocrine glands are bystanders in hidradenitis suppurativa and their involvement is gender specific. | 4.91e-04 | 59 | 90 | 3 | 32031713 | |
| Pubmed | 5.91e-04 | 14 | 90 | 2 | 21652651 | ||
| Pubmed | 6.19e-04 | 730 | 90 | 8 | 34857952 | ||
| Pubmed | 6.32e-04 | 402 | 90 | 6 | 24722188 | ||
| Pubmed | 6.69e-04 | 152 | 90 | 4 | 19578796 | ||
| Pubmed | 6.80e-04 | 15 | 90 | 2 | 30595533 | ||
| Pubmed | 7.76e-04 | 16 | 90 | 2 | 19068216 | ||
| Pubmed | 7.76e-04 | 16 | 90 | 2 | 29859889 | ||
| Pubmed | 8.78e-04 | 17 | 90 | 2 | 11781569 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.04e-04 | 774 | 90 | 8 | 15302935 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 9.17e-04 | 432 | 90 | 6 | 23455922 | |
| Pubmed | 9.31e-04 | 288 | 90 | 5 | 38496616 | ||
| Pubmed | 9.50e-04 | 167 | 90 | 4 | 25659891 | ||
| Pubmed | A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. | 9.86e-04 | 18 | 90 | 2 | 16085932 | |
| Pubmed | Genomewide discovery and classification of candidate ovarian fertility genes in the mouse. | 1.10e-03 | 19 | 90 | 2 | 17660561 | |
| Pubmed | 1.17e-03 | 622 | 90 | 7 | 14574404 | ||
| Pubmed | Mammalian Llgl2 is necessary for proper branching morphogenesis during placental development. | 1.22e-03 | 20 | 90 | 2 | 21606200 | |
| Pubmed | Impaired stria vascularis integrity upon loss of E-cadherin in basal cells. | 1.22e-03 | 20 | 90 | 2 | 21925491 | |
| Pubmed | PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4. | 1.22e-03 | 20 | 90 | 2 | 18715871 | |
| Pubmed | RPGRIP1 ZC3H7A DSP PYROXD1 SYNE1 SPTA1 RGS11 XPC TKTL1 DNAJC3 DNMT3B | 1.24e-03 | 1442 | 90 | 11 | 35575683 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PPP4R3B PPP2R2A USP24 AHCY KDM3B NUP188 DCK FERMT2 PRRC1 SNX1 PPP4R3A | 1.33e-03 | 1455 | 90 | 11 | 22863883 |
| Pubmed | 1.36e-03 | 638 | 90 | 7 | 31182584 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 1.37e-03 | 84 | 90 | 3 | 15203218 | |
| Pubmed | 1.44e-03 | 187 | 90 | 4 | 26460568 | ||
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 1.47e-03 | 86 | 90 | 3 | 10862698 | |
| Pubmed | 1.48e-03 | 22 | 90 | 2 | 25926459 | ||
| Pubmed | 1.51e-03 | 650 | 90 | 7 | 38777146 | ||
| Pubmed | 1.62e-03 | 23 | 90 | 2 | 19841136 | ||
| Pubmed | 1.67e-03 | 90 | 90 | 3 | 31280863 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.67e-03 | 853 | 90 | 8 | 28718761 | |
| Pubmed | 1.76e-03 | 24 | 90 | 2 | 17452356 | ||
| Pubmed | 1.76e-03 | 24 | 90 | 2 | 17937387 | ||
| Pubmed | 1.76e-03 | 24 | 90 | 2 | 32521258 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 1.77e-03 | 333 | 90 | 5 | 32665550 | |
| Pubmed | Systematic identification of pathological lamin A interactors. | 1.86e-03 | 337 | 90 | 5 | 24623722 | |
| Pubmed | Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. | 1.91e-03 | 25 | 90 | 2 | 15078902 | |
| Pubmed | A chemical tool for blue light-inducible proximity photo-crosslinking in live cells. | 1.91e-03 | 25 | 90 | 2 | 35211260 | |
| Pubmed | IGF2R DSP ENPP1 CALCOCO1 USP24 AHCY KDM3B NUP188 DNAJC3 SNX1 | 1.93e-03 | 1297 | 90 | 10 | 33545068 | |
| Pubmed | 2.00e-03 | 878 | 90 | 8 | 37223481 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 2.03e-03 | 344 | 90 | 5 | 36282215 | |
| Pubmed | 2.07e-03 | 26 | 90 | 2 | 27122033 | ||
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | 2.07e-03 | 26 | 90 | 2 | 30923192 | |
| Pubmed | 2.07e-03 | 97 | 90 | 3 | 25071155 | ||
| Pubmed | 2.16e-03 | 209 | 90 | 4 | 26389662 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.28e-03 | 212 | 90 | 4 | 33853758 | |
| Pubmed | 2.36e-03 | 214 | 90 | 4 | 22199357 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.39e-03 | 357 | 90 | 5 | 37059091 | |
| Pubmed | 2.39e-03 | 102 | 90 | 3 | 11214970 | ||
| Pubmed | 2.39e-03 | 102 | 90 | 3 | 10231032 | ||
| Pubmed | 2.40e-03 | 28 | 90 | 2 | 20346939 | ||
| Pubmed | 2.40e-03 | 28 | 90 | 2 | 20301750 | ||
| Pubmed | 2.44e-03 | 708 | 90 | 7 | 39231216 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.50e-03 | 361 | 90 | 5 | 26167880 | |
| Pubmed | 2.53e-03 | 104 | 90 | 3 | 10470851 | ||
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-07 | 188 | 90 | 7 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-06 | 176 | 90 | 6 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 2.02e-06 | 184 | 90 | 6 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 2.66e-06 | 193 | 90 | 6 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 2.74e-06 | 194 | 90 | 6 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.17e-06 | 199 | 90 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | severe-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.27e-06 | 200 | 90 | 6 | d6767f06fe13be8110a86c2a6029be2dd9ce666c | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 155 | 90 | 5 | 7a16df1a40c7255c24dfb9a921b62871554c7b6d | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 155 | 90 | 5 | f51a12556ca0a3416a6cf0687f908fb4e752fb2f | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.63e-05 | 156 | 90 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 159 | 90 | 5 | 796e63f6052189106359a4e01eae3e466bf1d593 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 163 | 90 | 5 | a763c1632d6465a1e753bdc8eadaf819d2b09e5e | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 163 | 90 | 5 | eaed783eecd07aafa5af844b63c9d816b4da99e4 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 163 | 90 | 5 | 924c666596bbb42d7876c9b164a725277f3efa5f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-05 | 165 | 90 | 5 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-05 | 165 | 90 | 5 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-05 | 165 | 90 | 5 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 175 | 90 | 5 | db977f18a71845ecb16ee3e6b3fb03dea4a1a8bc | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 175 | 90 | 5 | 7b38cbd73be26cf33393c6e6c804d62856a91ec3 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 177 | 90 | 5 | dba8b30a311051c22ca5f77697f5dbf9423c3ba0 | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 90 | 5 | d32b4e9c3d1f246ad49e2d8f6497989af68a6c00 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 90 | 5 | ba6ded4455233635a11afcf6f522c786bd81b5e0 | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 90 | 5 | b7abf5656233e1a9cdbbe978dfa84d16f14b0be0 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK|GI_small-bowel / Manually curated celltypes from each tissue | 3.15e-05 | 179 | 90 | 5 | 535bdfdd990ba9ee3edc8f3ad15297f8fb5a266e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.15e-05 | 179 | 90 | 5 | db76edd368eeca05a2a5d407c3eb2f535ade0ce3 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 3.50e-05 | 183 | 90 | 5 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.69e-05 | 185 | 90 | 5 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 186 | 90 | 5 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 186 | 90 | 5 | b099cb0902e9afb11218d70407d3cab212343c6d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 186 | 90 | 5 | e23e1246914e230369a716d0d666b98383bf8512 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.08e-05 | 189 | 90 | 5 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 4.19e-05 | 190 | 90 | 5 | e1f474dc36bf9eaf457b14a8761d287904754cdc | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 191 | 90 | 5 | 753deb090b7b78b4ef31604dbe5dbfc4dcf5184a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 191 | 90 | 5 | 355f5bcb220d917163833dead0050fc756c7b260 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 191 | 90 | 5 | 337d7d7b89fe370e1fe005b9daad76c5dc3b8444 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.40e-05 | 192 | 90 | 5 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.51e-05 | 193 | 90 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.62e-05 | 194 | 90 | 5 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK|Liver / Manually curated celltypes from each tissue | 4.62e-05 | 194 | 90 | 5 | 0b78f4ed84bbaca9f72f005c16c7492bb01d4328 | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.62e-05 | 194 | 90 | 5 | 335c6c2f3f319d4f19eace62f8826a0f40c130f6 | |
| ToppCell | T/NK_cells-CD8+_Naive_T_cell|World / Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | 43f11068beea076e9caeb1572215c3f65c9308e1 | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 4.74e-05 | 195 | 90 | 5 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.74e-05 | 195 | 90 | 5 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD16+_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.74e-05 | 195 | 90 | 5 | 7533822d2fe551f499b5b2fdec7172f56c79cb44 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.74e-05 | 195 | 90 | 5 | cab90c67a7b3119c0d0d2d5e84511c41dcb8765f | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 4.74e-05 | 195 | 90 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8|bone_marrow / Manually curated celltypes from each tissue | 4.85e-05 | 196 | 90 | 5 | 5c9ed3c6e3cbd43b52f0291b5c26dd7f9fadf3da | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.85e-05 | 196 | 90 | 5 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-05 | 196 | 90 | 5 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-05 | 196 | 90 | 5 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.85e-05 | 196 | 90 | 5 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-05 | 196 | 90 | 5 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-05 | 196 | 90 | 5 | 17f17edadafdad9f24e88d708d7e1c765503131c | |
| ToppCell | COVID-19_Severe-NK|World / disease group, cell group and cell class | 4.85e-05 | 196 | 90 | 5 | f46ca7cc2d8407d0dcaa77c4b16a2c1f2a23734d | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, condition lineage and cell class | 4.97e-05 | 197 | 90 | 5 | e3174e90ea6136f1aa3a4a185b86458e35d51fd4 | |
| ToppCell | COVID-19_Severe-NK_activated|World / disease group, cell group and cell class | 4.97e-05 | 197 | 90 | 5 | a60db36d1a192998e3ded63e0c7c08d41689f95f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.09e-05 | 198 | 90 | 5 | 24f6954aff8751885e783d68c631b04dd1980f48 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.09e-05 | 198 | 90 | 5 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.09e-05 | 198 | 90 | 5 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.09e-05 | 198 | 90 | 5 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.09e-05 | 198 | 90 | 5 | 4633e379893a26a746f8e29302cc54bbe04dd23f | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK|COVID-19_Convalescent / Disease group, lineage and cell class | 5.09e-05 | 198 | 90 | 5 | 457ba9e3f1bb6453af8cc1a6e7436af66296f8f5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.09e-05 | 198 | 90 | 5 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.09e-05 | 198 | 90 | 5 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.09e-05 | 198 | 90 | 5 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.09e-05 | 198 | 90 | 5 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | severe-NK|severe / disease stage, cell group and cell class | 5.09e-05 | 198 | 90 | 5 | cb505077dc5bdf3fdd513bb9032e32bb9644c004 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 5.22e-05 | 199 | 90 | 5 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.22e-05 | 199 | 90 | 5 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.22e-05 | 199 | 90 | 5 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | COVID-19_Moderate-NK|World / disease group, cell group and cell class | 5.22e-05 | 199 | 90 | 5 | c41b67b760831c7d5e19fabcc932a056dc560f93 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.22e-05 | 199 | 90 | 5 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.22e-05 | 199 | 90 | 5 | 4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.22e-05 | 199 | 90 | 5 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.22e-05 | 199 | 90 | 5 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.22e-05 | 199 | 90 | 5 | eb05ccae5187e4701bbbe6d714a6d2808fbcf306 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.22e-05 | 199 | 90 | 5 | 10c8729b779073c3bf808e85958d59147f0be5c5 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-05 | 199 | 90 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 5.22e-05 | 199 | 90 | 5 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.22e-05 | 199 | 90 | 5 | 867fd292f3879982422e840e087bfdb3b21a8715 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.22e-05 | 199 | 90 | 5 | 8f2b57cf2f932f20ea029132d8bda01aac774571 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.22e-05 | 199 | 90 | 5 | 5e9fe852a70546c9d235414a2c26ca3e67ba6eb9 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 5.22e-05 | 199 | 90 | 5 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.22e-05 | 199 | 90 | 5 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.22e-05 | 199 | 90 | 5 | d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 90 | 5 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-NK|IIF / Disease, condition lineage and cell class | 5.34e-05 | 200 | 90 | 5 | 4f889cc5ab76a128fd781d927b0d8368f4f927b7 | |
| ToppCell | severe-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 90 | 5 | 2253d74049cc49c92e897ff4aa298d913daeb739 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 5.34e-05 | 200 | 90 | 5 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 90 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 90 | 5 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK|COVID-19_Convalescent / Disease, condition lineage and cell class | 5.34e-05 | 200 | 90 | 5 | e94acbc62f8e9835413981ba6d0590a356afa05e | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | 0a6fc7eff94e2f71af9f31a01779aafd2f4a6699 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 5.34e-05 | 200 | 90 | 5 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.34e-05 | 200 | 90 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 90 | 5 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK|Leuk-UTI / Disease, condition lineage and cell class | 5.34e-05 | 200 | 90 | 5 | bb37fed4872e71f413ae7c4aa12586fa31075334 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.03e-04 | 120 | 90 | 4 | a6d0406a174d46ce06b41280292931954af88a59 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-04 | 136 | 90 | 4 | a43b3db1754c619d328a26a2ba6af4756629a723 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-04 | 140 | 90 | 4 | 568a008ff103269e9fe36aa95e9d302641efed98 | |
| Drug | HMDS | 1.67e-08 | 21 | 90 | 5 | CID000013838 | |
| Drug | Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; PC3; HT_HG-U133A | 1.29e-06 | 200 | 90 | 8 | 4077_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A | 1.37e-05 | 198 | 90 | 7 | 1163_UP | |
| Drug | Cefotetan [69712-56-7]; Down 200; 7uM; HL60; HT_HG-U133A | 1.42e-05 | 199 | 90 | 7 | 1319_DN | |
| Disease | ischemia (biomarker_via_orthology) | 2.02e-05 | 18 | 88 | 3 | DOID:326 (biomarker_via_orthology) | |
| Disease | lung adenocarcinoma (implicated_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:3910 (implicated_via_orthology) | |
| Disease | Hidradenitis Suppurativa | 1.83e-04 | 7 | 88 | 2 | C0162836 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.88e-04 | 301 | 88 | 6 | DOID:684 (is_marker_for) | |
| Disease | glioblastoma (is_marker_for) | 3.11e-04 | 44 | 88 | 3 | DOID:3068 (is_marker_for) | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 6.71e-04 | 13 | 88 | 2 | C0750905 | |
| Disease | colon carcinoma (is_marker_for) | 6.71e-04 | 13 | 88 | 2 | DOID:1520 (is_marker_for) | |
| Disease | Amino Acid Metabolism, Inborn Errors | 6.71e-04 | 13 | 88 | 2 | C0002514 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 1.27e-03 | 71 | 88 | 3 | EFO_0004735, EFO_0007965 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.74e-03 | 171 | 88 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.95e-03 | 22 | 88 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Hepatic Form of Wilson Disease | 2.33e-03 | 24 | 88 | 2 | C1527352 | |
| Disease | Hepatolenticular Degeneration | 2.33e-03 | 24 | 88 | 2 | C0019202 | |
| Disease | Noonan Syndrome | 2.33e-03 | 24 | 88 | 2 | C0028326 | |
| Disease | urate measurement, bone density | 2.53e-03 | 619 | 88 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | Micronuclei, Chromosome-Defective | 2.73e-03 | 26 | 88 | 2 | C1449861 | |
| Disease | Micronuclei, Genotoxicant-Induced | 2.73e-03 | 26 | 88 | 2 | C1449862 | |
| Disease | Colorectal cancer | 2.94e-03 | 27 | 88 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 2.94e-03 | 27 | 88 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 2.94e-03 | 27 | 88 | 2 | cv:C0009404 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LFIKDVIGDEICCWS | 201 | Q9H3F6 | |
| FWRQAKAEEEVSECV | 186 | P28222 | |
| IEGRTYDEKVDLWCI | 211 | Q9UQB9 | |
| ESDWGKRCVDKFDII | 716 | Q9NYV4 | |
| KEDVLWCTELERIFG | 796 | Q9UBC3 | |
| QWCFSQVKGAVDDDV | 11 | P63151 | |
| WEAGKPLCIEEVEVA | 16 | P08319 | |
| FVDVKEADWILEQLC | 96 | Q96Q83 | |
| PTLNEEEEWTCADFK | 226 | Q9Y2T1 | |
| KEVWGDEQADFVCNT | 41 | P29033 | |
| FLDKILEVCVWDAEL | 176 | Q13217 | |
| RSEVEEVDFAGWLCK | 371 | P36507 | |
| GWDTEIKDDVIEECN | 441 | Q14498 | |
| IVVEQWTVIEGCEIK | 341 | Q52LD8 | |
| DVVQWLAQKFCVSEE | 56 | O94810 | |
| ALSFQEKAGCDEIWE | 81 | Q6IN85 | |
| SEFKEWPLFCQEVEE | 461 | Q17RG1 | |
| ELSWEKIECESGVED | 701 | Q8WYB5 | |
| EDWIQCFSIEKAGAV | 561 | O75147 | |
| WTIREFKICGEEQLD | 1841 | P23467 | |
| IFTNGNCVAEEEVWK | 211 | Q96LZ2 | |
| VIFIKGNCASEEVIW | 236 | Q9UBF1 | |
| QLCVNEPFEETEEKW | 351 | Q9NXD2 | |
| VLVCLEEGWDITAQV | 1406 | Q86WG5 | |
| WDLEKFQVVSCIEGE | 216 | Q9BVA0 | |
| EDIQGHVTSVEEWKC | 406 | Q8N6G6 | |
| EIQYWGIDELSIDSC | 136 | Q6PIU1 | |
| KLFEVEEVNCICVDW | 111 | P54315 | |
| CHFEESGQDLEIWKE | 516 | Q9UHC1 | |
| EIEFCVWDQFLGEIN | 1126 | Q9C000 | |
| EELCVSKWSDPQVFE | 266 | Q9HD23 | |
| CAIISDVKVRDFWDG | 1451 | Q7LBC6 | |
| DVKVRDFWDGFEIIC | 1456 | Q7LBC6 | |
| QISALEEEICQIWGE | 406 | Q2M2I5 | |
| DCVVLDTDGFWKTVD | 1196 | O60449 | |
| GEKSWVEEPCESINE | 186 | P22413 | |
| ALIGELEAKECQSEW | 511 | O15553 | |
| ALSFQEKAGCDEIWE | 81 | Q5MIZ7 | |
| FWLESEVIIQVTDCE | 16 | A7KAX9 | |
| WIQLDTGEDVGCEEK | 846 | Q9C091 | |
| GFNLVSVKEFDCWEL | 71 | Q16821 | |
| CVDDTWNPKIFVVFD | 311 | Q9NR21 | |
| FQEGVCEIWLTSEDT | 246 | Q5VV42 | |
| GLEAAEDVEEWQVVC | 371 | Q8TCT0 | |
| EDVEEWQVVCGKFLA | 376 | Q8TCT0 | |
| LCEQECEWEEITITG | 2496 | P15924 | |
| WDFVDVSVQELLDCG | 171 | P56202 | |
| SCWETQGEKFIENLI | 3101 | Q0VDD8 | |
| EVTRAEWEQKDEFIC | 391 | P01854 | |
| GADIDCQWIDITDVK | 356 | P28300 | |
| TFVNILKQLCEDWEV | 36 | P27707 | |
| EETLNWKTEGICDYV | 776 | Q9NYC9 | |
| EQAKWAILLEEIECT | 296 | Q96AC1 | |
| EIKAQEDGSIWLECI | 156 | Q8WVV5 | |
| VCNIGHFDVEIDVKW | 296 | P23526 | |
| DWIGIFKVEAACVRD | 46 | Q9P1Z2 | |
| EEDEKACVLQVVWNG | 376 | O43933 | |
| AELKLFENIECEWPV | 316 | P46019 | |
| SDVDEIKFQEDGSWC | 411 | O75928 | |
| ELYLQWCDEATVGEI | 126 | O75431 | |
| EVRGCDVTFEWKTKV | 1971 | P11717 | |
| PIWEEQQCEVKADGF | 151 | P07204 | |
| AGWICFDRVLETVEK | 716 | Q96KN7 | |
| LEGKNTDEEIVECWH | 2986 | Q8NF91 | |
| TDEEIVECWHKGQEI | 2991 | Q8NF91 | |
| DWIEEKLQEVCEDLG | 181 | Q8N4C6 | |
| VEQVCSWLVEKNLGE | 6 | Q8N6K7 | |
| QILDWCGEAFEGVIV | 371 | Q9Y2G9 | |
| DKWFDIGCLVVEDPV | 341 | Q96M27 | |
| EVSLVCVVKPDEFWD | 91 | Q86VW0 | |
| DLVSWFEDCKEGKIE | 236 | Q8N999 | |
| FDKDNDGCVNVLEWI | 76 | Q9HAE3 | |
| DCWLPVVKFIEEQFE | 106 | Q8WYJ6 | |
| RGCVTQLWSKEDEED | 41 | Q96A61 | |
| EEFGESKWDSNICEL | 406 | Q63HN8 | |
| SIVEELCAWVEKFIN | 3186 | Q63HN8 | |
| DVAIEFPQEEWKCLD | 11 | Q6PDB4 | |
| DVAIEFSQEEWKCLE | 11 | Q08AN1 | |
| LQACEELVKTLGFDW | 1656 | Q8IZQ1 | |
| VDIAKSEIFNGDVEW | 361 | Q9NZQ8 | |
| SEIFNGDVEWKSCDL | 366 | Q9NZQ8 | |
| DIWFEEKLQEVECEE | 306 | Q13596 | |
| AKEEEAFWLLVAVCE | 586 | Q0IIM8 | |
| IEGCEVIWAIKDKAI | 166 | Q8WU10 | |
| ELGELVFKDWSVVIE | 236 | Q6P2S7 | |
| KELCEVDEDGDSWLQ | 1291 | Q5SRE5 | |
| IHFITFCQEKGVDEW | 61 | Q6BDI9 | |
| ECADILEWIGDKEAI | 166 | P02549 | |
| KDVAIEFSQEEWECL | 11 | Q86XU0 | |
| CQEEIDVWTLERKGA | 526 | Q8IWR0 | |
| AKEIWECLVTGQDVC | 731 | Q9UPU5 | |
| KEVLCWEQEGTTVEA | 421 | Q7Z7G8 | |
| IEFSQEEWKCLDPVQ | 16 | Q5HY98 | |
| AGIDQWLEVFCEQEE | 526 | Q01831 | |
| LEQEDAFWCLVTIVE | 766 | Q9UPU7 | |
| VVDGRDVEALCQVFW | 186 | P51854 |